Precision Medical Bhrt Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1691 Forum Pl Ste B164, West Palm Bch, FL 33401 Phone: 561-794-5068 |
Cece Mobile Clinic Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 1323 Pebble Ridge Ln, West Palm Bch, FL 33411 Phone: 561-386-9229 Fax: 561-366-7574 |
Wellness Centers Of South Florida Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 534 Datura St, West Palm Bch, FL 33401 Phone: 954-895-2862 |
Sterling Hospitalists Of Florida Pa Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 901 45th St, West Palm Bch, FL 33407 Phone: 561-844-6300 |
Cruz Azul Of Wpb General Practice Medicare: Not Enrolled in Medicare Practice Location: 6294 18th St S, West Palm Bch, FL 33415 Phone: 561-201-4016 |
News Archive
GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it is in final negotiations with Beckpharma Ltd. ("Beckpharma") -a pharmaceutical development company also involved in cancer treatments for an extensive collaboration agreement.
A recent multi-center study determined that women with generalized tonic-clonic seizures (GTCS) had a greater number of seizures during anovulatory cycles-menstrual cycles where an egg is not released-than in cycles where ovulation occurs. According to the study publishing today in Epilepsia, a journal of the International League Against Epilepsy (ILAE), reproductive steroids may play a role in GTCS occurrence.
An international team of tropical medicine researchers have discovered a potential method for preventing low birth weight in babies born to pregnant women who are exposed to malaria. Low birth weight is the leading cause of infant death globally.
A new study has found that while the cost of fresh food is becoming more and more expensive junk food is becoming cheaper.
Anavex Life Sciences Corp. announced today that it has filed the regulatory submission for ANAVEX 2-73 with the German Health Authority, BfArM, and the local Ethics Committee of Saxony to begin clinical studies for ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease.
› Verified 7 days ago